BioMarin Pharmaceutical Gross Margin 2012-2025 | BMRN

Current and historical gross margin for BioMarin Pharmaceutical (BMRN) over the last 10 years. The current gross profit margin for BioMarin Pharmaceutical as of September 30, 2025 is %.

BioMarin Pharmaceutical Gross Margin Historical Data
Date	TTM Revenue	TTM Gross Profit	Gross Margin
2025-09-30	$3.09B	$2.52B	81.34%
2025-06-30	$3.06B	$2.44B	79.56%
2025-03-31	$2.95B	$2.34B	79.46%
2024-12-31	$2.85B	$2.27B	79.68%
2024-09-30	$2.75B	$2.17B	78.86%
2024-06-30	$2.59B	$2.07B	79.87%
2024-03-31	$2.47B	$1.95B	78.92%
2023-12-31	$2.42B	$1.89B	78.04%
2023-09-30	$2.31B	$1.77B	76.62%
2023-06-30	$2.23B	$1.71B	76.37%
2023-03-31	$2.17B	$1.65B	76.02%
2022-12-31	$2.10B	$1.59B	76.00%
2022-09-30	$2.01B	$1.53B	76.29%
2022-06-30	$1.91B	$1.45B	75.73%
2022-03-31	$1.88B	$1.41B	75.11%
2021-12-31	$1.85B	$1.38B	74.50%
2021-09-30	$1.85B	$1.37B	74.20%
2021-06-30	$1.92B	$1.36B	70.68%
2021-03-31	$1.84B	$1.31B	71.15%
2020-12-31	$1.86B	$1.34B	71.88%
2020-09-30	$1.86B	$1.37B	73.58%
2020-06-30	$1.85B	$1.45B	78.33%
2020-03-31	$1.81B	$1.42B	78.89%
2019-12-31	$1.70B	$1.35B	78.93%
2019-09-30	$1.60B	$1.26B	78.85%
2019-06-30	$1.53B	$1.21B	79.07%
2019-03-31	$1.52B	$1.20B	78.80%
2018-12-31	$1.49B	$1.18B	78.87%
2018-09-30	$1.50B	$1.18B	78.88%
2018-06-30	$1.44B	$1.14B	79.42%
2018-03-31	$1.38B	$1.11B	80.25%
2017-12-31	$1.31B	$1.07B	81.65%
2017-09-30	$1.26B	$1.03B	81.75%
2017-06-30	$1.20B	$0.98B	81.60%
2017-03-31	$1.18B	$0.97B	81.76%
2016-12-31	$1.12B	$0.91B	81.29%
2016-09-30	$1.05B	$0.85B	81.53%
2016-06-30	$0.97B	$0.80B	81.83%
2016-03-31	$0.92B	$0.76B	82.25%
2015-12-31	$0.89B	$0.74B	82.92%
2015-09-30	$0.89B	$0.75B	84.06%
2015-06-30	$0.86B	$0.72B	84.05%
2015-03-31	$0.80B	$0.67B	83.77%
2014-12-31	$0.75B	$0.63B	83.73%
2014-09-30	$0.67B	$0.57B	84.88%
2014-06-30	$0.63B	$0.53B	84.24%
2014-03-31	$0.57B	$0.48B	84.12%
2013-12-31	$0.55B	$0.46B	83.79%
2013-09-30	$0.53B	$0.44B	81.46%
2013-06-30	$0.53B	$0.43B	81.71%
2013-03-31	$0.51B	$0.42B	81.05%
2012-12-31	$0.50B	$0.41B	81.44%
2012-09-30	$0.48B	$0.39B	81.55%
2012-06-30	$0.46B	$0.38B	81.60%
2012-03-31	$0.45B	$0.37B	81.96%
2011-12-31	$0.44B	$0.36B	80.95%
2011-09-30	$0.44B	$0.35B	80.92%
2011-06-30	$0.42B	$0.34B	81.19%
2011-03-31	$0.40B	$0.33B	81.80%
2010-12-31	$0.38B	$0.31B	81.43%
2010-09-30	$0.36B	$0.30B	81.77%
2010-06-30	$0.35B	$0.28B	81.74%
2010-03-31	$0.34B	$0.27B	79.46%
2009-12-31	$0.33B	$0.26B	79.69%
2009-09-30	$0.34B	$0.28B	82.20%
2009-06-30	$0.33B	$0.27B	82.07%
2009-03-31	$0.31B	$0.26B	84.52%
2008-12-31	$0.30B	$0.25B	82.77%
2008-09-30	$0.24B	$0.20B	81.40%
2008-06-30	$0.19B	$0.16B	81.96%
2008-03-31	$0.16B	$0.13B	80.50%
2007-12-31	$0.12B	$0.10B	85.25%
2007-09-30	$0.08B	$0.07B	79.52%
2007-06-30	$0.08B	$0.07B	80.72%
2007-03-31	$0.08B	$0.07B	85.71%
2006-12-31	$0.07B	$0.06B	86.76%
2006-09-30	$0.06B	$0.06B	88.89%
2006-06-30	$0.05B	$0.04B	89.13%
2006-03-31	$0.03B	$0.02B	77.78%
2005-12-31	$0.02B	$0.01B	72.22%
2005-09-30	$0.03B	$0.03B	80.65%
2005-06-30	$0.02B	$0.02B	78.26%
2005-03-31	$0.02B	$0.02B	79.17%
2004-09-30	$0.01B	$0.00B	80.00%
2002-12-31	$0.01B	$0.01B	100.00%
2002-03-31	$0.01B	$0.01B	100.00%
2001-12-31	$0.01B	$0.01B	100.00%
2001-09-30	$0.01B	$0.01B	100.00%
2001-06-30	$0.01B	$0.01B	100.00%
2001-03-31	$0.01B	$0.01B	100.00%
2000-12-31	$0.01B	$0.01B	100.00%
2000-09-30	$0.01B	$0.01B	100.00%
2000-06-30	$0.01B	$0.01B	100.00%
2000-03-31	$0.01B	$0.00B	80.00%
1999-12-31	$0.00B	$0.00B	66.67%
1999-09-30	$0.01B	$0.01B	83.33%
1999-06-30	$0.00B	$0.00B	75.00%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$10.818B	$2.854B
BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder), Vimizim , Brineura, Palynziq and Voxzogo. BioMarin has a collaboration agreement with Sanofi's subsidiary Genzyme for Aldurazyme. Genzyme is BioMarin's sole customer for Aldurazyme and is responsible for marketing and selling Aldurazyme to third parties.?The newest drug in BioMarin's portfolio, Voxzogo for treating achondroplasia, the most common form of dwarfism. BioMarin's biologics license application (BLA) for Roctavian/valoctocogene roxaparvovec (valrox), a gene therapy for severe hemophilia A, was given a complete response letter (CRL) by the FDA.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$278.977B	19.68
Amgen (AMGN)	United States	$178.237B	15.14
Gilead Sciences (GILD)	United States	$154.018B	15.16
Vertex Pharmaceuticals (VRTX)	United States	$112.164B	28.88
Bristol Myers Squibb (BMY)	United States	$110.379B	8.27
GSK (GSK)	United Kingdom	$97.130B	10.76
Regeneron Pharmaceuticals (REGN)	United States	$77.120B	20.00
CSL (CSLLY)	Australia	$57.549B	0.00
Argenex SE (ARGX)	Netherlands	$50.103B	61.90
Alnylam Pharmaceuticals (ALNY)	United States	$46.970B	1545.78
Insmed (INSM)	United States	$34.872B	0.00
Biogen (BIIB)	United States	$24.262B	9.88
BioNTech SE (BNTX)	Germany	$23.770B	0.00
Royalty Pharma (RPRX)	United States	$22.564B	8.65
Illumina (ILMN)	United States	$22.488B	33.76
Revolution Medicines (RVMD)	United States	$22.468B	0.00
Genmab (GNMSF)	Denmark	$21.829B	16.01
Incyte (INCY)	United States	$20.147B	19.29
Genmab (GMAB)	Denmark	$20.126B	15.14
Exact Sciences (EXAS)	United States	$19.529B	538.68
Moderna (MRNA)	United States	$16.802B	0.00
Roivant Sciences (ROIV)	United Kingdom	$15.982B	0.00
Guardant Health (GH)	United States	$14.478B	0.00
Ascendis Pharma (ASND)	Denmark	$13.361B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	24.50
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$12.026B	0.00
Exelixis (EXEL)	United States	$11.738B	18.79
QIAGEN (QGEN)	Netherlands	$11.710B	22.23
Avidity Biosciences (RNA)	United States	$10.919B	0.00
Bio-Techne Corp (TECH)	United States	$10.839B	40.44
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.201B	39.78
Abivax SA (ABVX)	France	$9.322B	0.00
Axsome Therapeutics (AXSM)	United States	$9.301B	0.00
Repligen (RGEN)	United States	$9.194B	98.39
Arrowhead Pharmaceuticals (ARWR)	United States	$8.870B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$8.436B	30.33
Halozyme Therapeutics (HALO)	United States	$8.282B	13.24
Praxis Precision Medicines (PRAX)	United States	$8.165B	0.00
Krystal Biotech (KRYS)	United States	$7.969B	41.20
Cytokinetics (CYTK)	United States	$7.798B	0.00
Nuvalent (NUVL)	United States	$7.702B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.846B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
ImmunityBio (IBRX)	United States	$6.383B	0.00
Vaxcyte (PCVX)	United States	$6.221B	0.00
Belite Bio (BLTE)	United States	$6.003B	0.00
PTC Therapeutics (PTCT)	United States	$5.867B	7.97
Cogent Biosciences (COGT)	United States	$5.681B	0.00
Apogee Therapeutics (APGE)	United States	$5.605B	0.00
Structure Therapeutics (GPCR)	United States	$5.523B	0.00
Alkermes (ALKS)	Ireland	$5.242B	15.41
Protagonist Therapeutics (PTGX)	United States	$5.215B	134.55
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.014B	0.00
TG Therapeutics (TGTX)	United States	$4.912B	11.13
Kymera Therapeutics (KYMR)	United States	$4.903B	0.00
Celcuity (CELC)	United States	$4.877B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$4.723B	0.00
Immunovant (IMVT)	United States	$4.582B	0.00
Scholar Rock Holding (SRRK)	United States	$4.564B	0.00
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.475B	4.53
ACADIA Pharmaceuticals (ACAD)	United States	$4.448B	37.56
Anbio Biotechnology (NNNN)	Germany	$4.433B	0.00
Amicus Therapeutics (FOLD)	United States	$4.415B	357.75
CG Oncology (CGON)	United States	$4.412B	0.00
Legend Biotech (LEGN)	United States	$4.325B	0.00
ADMA Biologics Inc (ADMA)	United States	$4.186B	29.81
Arcellx (ACLX)	United States	$4.173B	0.00
GRAIL (GRAL)	United States	$3.949B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.869B	94.96
Viking Therapeutics (VKTX)	United States	$3.789B	0.00
Liquidia (LQDA)	United States	$3.424B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.295B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.206B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.169B	0.00
Beam Therapeutics (BEAM)	United States	$3.142B	0.00
IDEAYA Biosciences (IDYA)	United States	$3.134B	0.00
Viridian Therapeutics (VRDN)	United States	$3.115B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.110B	91.18
Edgewise Therapeutics (EWTX)	United States	$3.042B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$3.011B	0.00
Vera Therapeutics (VERA)	United States	$2.866B	0.00
Disc Medicine (IRON)	United States	$2.794B	0.00
Erasca (ERAS)	United States	$2.783B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.728B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.725B	0.00
Alumis (ALMS)	United States	$2.720B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.619B	0.00
Spyre Therapeutics (SYRE)	United States	$2.617B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.590B	66.03
Denali Therapeutics (DNLI)	United States	$2.571B	0.00
Twist Bioscience (TWST)	United States	$2.552B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.527B	0.00
Travere Therapeutics (TVTX)	United States	$2.500B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.428B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.418B	6.56
Arcus Biosciences (RCUS)	United States	$2.370B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.310B	0.00
Recursion Pharmaceuticals (RXRX)	United States	$2.287B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.205B	0.00
Immunome (IMNM)	United States	$2.190B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.183B	0.00
Mesoblast (MESO)	Australia	$2.159B	0.00
Maze Therapeutics (MAZE)	United States	$2.134B	0.00
Zai Lab (ZLAB)	China	$2.117B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.068B	11.29
Nuvation Bio (NUVB)	United States	$2.060B	0.00
Dianthus Therapeutics (DNTH)	United States	$1.998B	0.00
MBX Biosciences (MBX)	United States	$1.937B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.927B	14.94
Dynavax Technologies (DVAX)	United States	$1.841B	54.07
Vericel (VCEL)	United States	$1.835B	151.21
Olema Pharmaceuticals (OLMA)	United States	$1.835B	0.00
Sionna Therapeutics (SION)	United States	$1.786B	0.00
Zymeworks (ZYME)	United States	$1.771B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.758B	0.00
MannKind (MNKD)	United States	$1.686B	54.90
Tango Therapeutics (TNGX)	United States	$1.685B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.684B	0.00
Upstream Bio (UPB)	United States	$1.675B	0.00
Celldex Therapeutics (CLDX)	United States	$1.671B	0.00
Mind Medicine (MindMed) (DFTX)	United States	$1.653B	0.00
Stoke Therapeutics (STOK)	United States	$1.640B	42.87
NeoGenomics (NEO)	United States	$1.635B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.599B	0.00
Rapt Therapeutics (RAPT)	United States	$1.595B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.591B	76.38
Tyra Biosciences (TYRA)	United States	$1.575B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.556B	0.00
Precigen (PGEN)	United States	$1.553B	0.00
Certara (CERT)	United States	$1.512B	27.91
Alvotech (ALVO)	Luxembourg	$1.495B	21.57
Intellia Therapeutics (NTLA)	United States	$1.486B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Fortrea Holdings (FTRE)	United States	$1.462B	31.02
NovoCure (NVCR)	Jersey	$1.457B	0.00
Kodiak Sciences (KOD)	United States	$1.413B	0.00
Nurix Therapeutics (NRIX)	United States	$1.402B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.398B	0.00
UniQure (QURE)	Netherlands	$1.395B	0.00
Pharvaris (PHVS)	Netherlands	$1.371B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.362B	0.00
Biohaven (BHVN)	United States	$1.342B	0.00
Trevi Therapeutics (TRVI)	United States	$1.336B	0.00
Novavax (NVAX)	United States	$1.332B	3.39
Oxford BioMedica (OXBDF)	United Kingdom	$1.309B	0.00
EyePoint (EYPT)	United States	$1.287B	0.00
AnaptysBio (ANAB)	United States	$1.279B	0.00
Pharming Group (PHAR)	Netherlands	$1.257B	0.00
AbCellera Biologics (ABCL)	Canada	$1.245B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.243B	0.00
Pharming Group (PHGUF)	Netherlands	$1.241B	185.00
Rapport Therapeutics (RAPP)	United States	$1.238B	0.00
Sana Biotechnology (SANA)	United States	$1.220B	0.00
Septerna (SEPN)	United States	$1.210B	0.00
Immatics (IMTX)	Germany	$1.200B	0.00
Castle Biosciences (CSTL)	United States	$1.193B	163.44
Palvella Therapeutics (PVLA)	United States	$1.160B	0.00
Oric Pharmaceuticals (ORIC)	United States	$1.132B	0.00
Zenas BioPharma (ZBIO)	United States	$1.121B	0.00
Inhibrx Biosciences (INBX)	United States	$1.060B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.049B	0.00
Nanobiotix S.A - (NBTX)	France	$1.016B	0.00
Compass Therapeutics (CMPX)	United States	$1.016B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$1.011B	0.00
Ventyx Biosciences (VTYX)	United States	$0.990B	0.00
Iovance Biotherapeutics (IOVA)	United States	$0.969B	0.00
Inventiva S.A (IVA)	France	$0.938B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
ArriVent BioPharma (AVBP)	United States	$0.919B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.917B	0.00
Bicara Therapeutics (BCAX)	United States	$0.916B	0.00
CytomX Therapeutics (CTMX)	United States	$0.910B	13.43
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.908B	0.00
Urogen Pharma (URGN)	United States	$0.905B	0.00
YD Bio (YDES)		$0.843B	0.00
DBV Technologies S.A (DBVT)	France	$0.839B	0.00
Vir Biotechnology (VIR)	United States	$0.835B	0.00
Pacira BioSciences (PCRX)	United States	$0.830B	9.51
Geron (GERN)	United States	$0.830B	0.00
GH Research (GHRS)	Ireland	$0.819B	0.00
Arbutus Biopharma (ABUS)	United States	$0.809B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.808B	0.00
MiMedx (MDXG)	United States	$0.798B	14.18
Janux Therapeutics (JANX)	United States	$0.791B	0.00
MapLight Therapeutics (MPLT)	United States	$0.773B	0.00
Arvinas (ARVN)	United States	$0.773B	0.00
BioAge Labs (BIOA)	United States	$0.764B	0.00
Gyre Therapeutics (GYRE)	United States	$0.764B	99.12
Jade Biosciences (JBIO)	United States	$0.752B	0.00
Kura Oncology (KURA)	United States	$0.748B	0.00
Annexon (ANNX)	United States	$0.737B	0.00
REGENXBIO (RGNX)	United States	$0.714B	0.00
Astria Therapeutics (ATXS)	United States	$0.710B	0.00
Prime Medicine (PRME)	United States	$0.702B	0.00
Cytek Biosciences (CTKB)	United States	$0.679B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.642B	0.00
SELLAS Life Sciences (SLS)	United States	$0.615B	0.00
EnGene Holdings (ENGN)	Canada	$0.610B	0.00
LENZ Therapeutics (LENZ)	United States	$0.606B	0.00
Gossamer Bio (GOSS)	United States	$0.602B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.589B	0.00
Emergent Biosolutions (EBS)	United States	$0.583B	5.61
Evommune (EVMN)	United States	$0.580B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.574B	0.00
Keros Therapeutics (KROS)	United States	$0.561B	11.97
Replimune (REPL)	United States	$0.550B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.547B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.545B	0.00
CorMedix Inc (CRMD)	United States	$0.542B	5.02
Alto Neuroscience (ANRO)	United States	$0.541B	0.00
Design Therapeutics (DSGN)	United States	$0.538B	0.00
Myriad Genetics (MYGN)	United States	$0.529B	0.00
Invivyd (IVVD)	United States	$0.522B	0.00
Ocugen (OCGN)	United States	$0.522B	0.00
Prothena (PRTA)	Ireland	$0.498B	0.00
Niagen Bioscience (NAGE)	United States	$0.496B	38.81
Lexicon Pharmaceuticals (LXRX)	United States	$0.476B	0.00
Monopar Therapeutics (MNPR)	United States	$0.470B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.463B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.459B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.456B	0.00
NovaBridge Biosciences (NBP)	United States	$0.452B	0.00
Anavex Life Sciences (AVXL)	United States	$0.449B	0.00
Kamada (KMDA)	Israel	$0.449B	21.69
Verastem (VSTM)	United States	$0.444B	0.00
PureTech Health (PRTC)	United States	$0.438B	0.00
Solid Biosciences (SLDB)	United States	$0.438B	0.00
Absci (ABSI)	United States	$0.436B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.436B	0.00
Prima BioMed (IMMP)	Australia	$0.414B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.412B	0.00
PepGen (PEPG)	United States	$0.409B	0.00
Entrada Therapeutics (TRDA)	United States	$0.406B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.395B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.394B	0.00
Benitec Biopharma (BNTC)	United States	$0.394B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.386B	0.00
Forte Biosciences (FBRX)	United States	$0.381B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.378B	0.00
BGM Group (BGM)	China	$0.367B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.360B	0.00
Tectonic Therapeutic (TECX)	United States	$0.357B	0.00
Allogene Therapeutics (ALLO)	United States	$0.353B	0.00
Contineum Therapeutics (CTNM)	United States	$0.346B	0.00
Aardvark Therapeutics (AARD)	United States	$0.338B	0.00
AC Immune (ACIU)	Switzerland	$0.333B	0.00
Puma Biotechnology (PBYI)	United States	$0.333B	8.92
Zura Bio (ZURA)	United States	$0.326B	0.00
Candel Therapeutics (CADL)	United States	$0.325B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.324B	0.00
XOMA Royalty (XOMA)	United States	$0.323B	0.00
Amarin (AMRN)	Ireland	$0.322B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.321B	0.00
Aura Biosciences (AURA)	United States	$0.316B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.315B	0.00
Neumora Therapeutics (NMRA)	United States	$0.312B	0.00
Lifecore Biomedical (LFCR)	United States	$0.309B	0.00
Immuneering (IMRX)	United States	$0.309B	0.00
GENFIT S.A (GNFTY)	France	$0.299B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.295B	0.00
Climb Bio (CLYM)	United States	$0.295B	0.00
Abeona Therapeutics (ABEO)	United States	$0.288B	4.70
Palisade Bio (PALI)	United States	$0.282B	0.00
Shattuck Labs (STTK)	United States	$0.275B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.273B	0.00
Neurogene (NGNE)	United States	$0.271B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.269B	0.00
Rezolute (RZLT)	United States	$0.268B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.259B	0.00
Adherex Technologies (FENC)	United States	$0.252B	0.00
Jyong Biotech (MENS)	Taiwan	$0.248B	0.00
Immix Biopharma (IMMX)	United States	$0.244B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.228B	0.00
C4 Therapeutics (CCCC)	United States	$0.211B	0.00
Cabaletta Bio (CABA)	United States	$0.211B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.208B	0.00
Nuvectis Pharma (NVCT)	United States	$0.208B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.207B	0.00
Sagimet Biosciences (SGMT)	United States	$0.204B	0.00
Voyager Therapeutics (VYGR)	United States	$0.204B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.202B	0.00
Alector (ALEC)	United States	$0.200B	0.00
Editas Medicine (EDIT)	United States	$0.197B	0.00
Compugen (CGEN)	Israel	$0.195B	0.00
Crescent Biopharma (CBIO)	United States	$0.194B	0.00
Humacyte (HUMA)	United States	$0.191B	0.00
SAB Biotherapeutics (SABS)	United States	$0.191B	0.00
Quince Therapeutics (QNCX)	United States	$0.190B	0.00
Cardiff Oncology (CRDF)	United States	$0.189B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.188B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.188B	0.00
Coherus Oncology (CHRS)	United States	$0.187B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.183B	0.00
Vor Biopharma (VOR)		$0.183B	0.00
Alpha Teknova (TKNO)	United States	$0.180B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.177B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.171B	0.00
Innate Pharma S.A (IPHA)	France	$0.170B	0.00
Alps Group (ALPS)	United States	$0.168B	3.06
Rani Therapeutics Holdings (RANI)	United States	$0.165B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.164B	0.00
Opus Genetics (IRD)	United States	$0.156B	0.00
Codexis (CDXS)	United States	$0.145B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Nkarta (NKTX)	United States	$0.145B	0.00
Elicio Therapeutics (ELTX)	United States	$0.139B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.137B	6.67
Anika Therapeutics (ANIK)	United States	$0.136B	0.00
Seres Therapeutics (MCRB)	United States	$0.136B	0.00
Turn Therapeutics (TTRX)	United States	$0.136B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.135B	0.00
Spero Therapeutics (SPRO)	United States	$0.134B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.132B	0.00
Caribou Biosciences (CRBU)	United States	$0.130B	0.00
Actuate Therapeutics (ACTU)	United States	$0.129B	0.00
MaxCyte (MXCT)	United States	$0.129B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.129B	0.00
Sutro Biopharma (STRO)	United States	$0.127B	0.00
Fate Therapeutics (FATE)	United States	$0.127B	0.00
VTv Therapeutics (VTVT)	United States	$0.126B	0.00
Cognition Therapeutics (CGTX)	United States	$0.124B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.123B	0.00
Alpha Cognition (ACOG)	Canada	$0.121B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.117B	0.00
Agenus (AGEN)	United States	$0.115B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.113B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.113B	0.00
Repare Therapeutics (RPTX)	Canada	$0.111B	0.00
Tharimmune (THAR)	United States	$0.109B	0.00
Ovid Therapeutics (OVID)	United States	$0.108B	0.00
Fortress Biotech (FBIO)	United States	$0.108B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.105B	0.00
Genelux (GNLX)	United States	$0.104B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.104B	0.00
Seer (SEER)	United States	$0.104B	0.00
Tenax Therapeutics (TENX)	United States	$0.103B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.101B	0.00
Biomea Fusion (BMEA)	United States	$0.098B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Coya Therapeutics (COYA)	United States	$0.094B	0.00
EXoZymes (EXOZ)	United States	$0.093B	0.00
Scilex Holding (SCLX)	United States	$0.092B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.090B	0.00
Citius Oncology (CTOR)	United States	$0.089B	0.00
Adagene (ADAG)	China	$0.088B	0.00
MediciNova (MNOV)	United States	$0.083B	0.00
OKYO Pharma (OKYO)		$0.081B	0.00
CalciMedica (CALC)	United States	$0.081B	0.00
BioHarvest Sciences (BHST)	Canada	$0.079B	0.00
Pliant Therapeutics (PLRX)	United States	$0.079B	0.00
Immunic (IMUX)	United States	$0.078B	0.00
XBiotech (XBIT)	United States	$0.077B	0.00
Spruce Biosciences (SPRB)	United States	$0.076B	0.00
Adicet Bio (ACET)	United States	$0.076B	0.00
Annovis Bio (ANVS)	United States	$0.074B	0.00
Entera Bio (ENTX)	Israel	$0.072B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.072B	0.00
ImageneBio (IMA)	United States	$0.070B	0.00
Equillium (EQ)	United States	$0.070B	0.00
ATyr Pharma (ATYR)	United States	$0.069B	0.00
BeyondSpring (BYSI)	United States	$0.069B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.068B	0.00
InflaRx (IFRX)	Germany	$0.066B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.066B	0.00
CervoMed (CRVO)	United States	$0.065B	0.00
BioStem Technologies (BSEM)		$0.065B	4.52
TScan Therapeutics (TCRX)	United States	$0.064B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.063B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.061B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.059B	0.00
MiNK Therapeutics (INKT)	United States	$0.055B	0.00
Precision BioSciences (DTIL)	United States	$0.055B	0.00
Grace Therapeutics (GRCE)	United States	$0.055B	0.00
ABVC BioPharma (ABVC)	United States	$0.052B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.052B	0.00
Clene (CLNN)	United States	$0.051B	0.00
IBio (IBIO)	United States	$0.050B	0.00
Aligos Therapeutics (ALGS)	United States	$0.049B	0.00
Q32 Bio (QTTB)	United States	$0.048B	0.00
Instil Bio (TIL)	United States	$0.048B	0.00
NextCure (NXTC)	United States	$0.047B	0.00
PDS Biotechnology (PDSB)	United States	$0.046B	0.00
Kezar Life Sciences (KZR)	United States	$0.045B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.045B	0.00
Galecto (GLTO)	Denmark	$0.045B	0.00
Cingulate (CING)	United States	$0.044B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.043B	0.00
Jasper Therapeutics (JSPR)	United States	$0.043B	0.00
INmune Bio (INMB)	United States	$0.043B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.041B	0.00
Passage Bio (PASG)	United States	$0.041B	0.00
OnKure Therapeutics (OKUR)	United States	$0.040B	0.00
Lantern Pharma (LTRN)	United States	$0.040B	0.00
Femasys (FEMY)	United States	$0.040B	0.00
Exicure (XCUR)	United States	$0.039B	0.00
RenovoRx (RNXT)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.038B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
TELA Bio (TELA)	United States	$0.038B	0.00
IO Biotech (IOBT)	Denmark	$0.037B	0.00
Elutia (ELUT)	United States	$0.036B	0.00
TuHURA Biosciences (HURA)	United States	$0.035B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.035B	0.00
Medicus Pharma (MDCX)	United States	$0.034B	0.00
Estrella Immunopharma (ESLA)	United States	$0.034B	0.00
Oncobiologics (OTLK)	United States	$0.033B	0.00
Xilio Therapeutics (XLO)	United States	$0.033B	0.00
AN2 Therapeutics (ANTX)	United States	$0.032B	0.00
Dyadic (DYAI)	United States	$0.032B	0.00
Rein Therapeutics (RNTX)	United States	$0.032B	0.00
Skye Bioscience (SKYE)	United States	$0.031B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.031B	1.98
Pluri (PLUR)	Israel	$0.031B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.029B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.029B	0.00
Senti Biosciences (SNTI)	United States	$0.028B	0.00
Dare Bioscience (DARE)	United States	$0.028B	0.00
Quantum Biopharma (QNTM)	Canada	$0.028B	0.00
Boundless Bio (BOLD)	United States	$0.028B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.027B	0.00
Aytu BioPharma (AYTU)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
Rallybio (RLYB)	United States	$0.026B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.026B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.025B	0.00
Athira Pharma (LONA)	United States	$0.024B	0.00
Intensity Therapeutics (INTS)	United States	$0.024B	0.00
Cue Biopharma (CUE)	United States	$0.024B	0.00
Hyperion DeFi (HYPD)	United States	$0.023B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.023B	0.00
Apollomics (APLM)	United States	$0.022B	0.00
Black Titan (BTTC)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
FibroBiologics (FBLG)	United States	$0.021B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.021B	0.00
Lisata Therapeutics (LSTA)	United States	$0.019B	0.00
BioAtla (BCAB)	United States	$0.019B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.019B	0.00
Allarity Therapeutics (ALLR)	United States	$0.018B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.018B	0.00
Promis Neurosciences (PMN)	Canada	$0.018B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.017B	0.00
Hoth Therapeutics (HOTH)	United States	$0.017B	0.00
Beyond Air (XAIR)	United States	$0.016B	0.00
Applied Therapeutics (APLT)	United States	$0.015B	0.00
Polyrizon (PLRZ)	Israel	$0.015B	0.00
Bionano Genomics (BNGO)	United States	$0.015B	0.00
Cocrystal Pharma (COCP)	United States	$0.014B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
BioCardia (BCDA)	United States	$0.014B	0.00
Curis (CRIS)	United States	$0.013B	0.00
Edesa Biotech (EDSA)	Canada	$0.012B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.012B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.012B	0.00
Novogen (KZIA)	Australia	$0.012B	0.00
Longeveron (LGVN)	United States	$0.011B	0.00
NewcelX (NCEL)	Switzerland	$0.011B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
Mainz Biomed (MYNZ)	Germany	$0.010B	0.00
IN8bio (INAB)	United States	$0.010B	0.00
Biorestorative Therapies (BRTX)	United States	$0.010B	0.00
Gelteq (GELS)	Australia	$0.010B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.010B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.010B	0.00
Biofrontera (BFRI)	United States	$0.010B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.009B	0.00
Aptevo Therapeutics (APVO)	United States	$0.009B	0.00
Alzamend Neuro (ALZN)	United States	$0.009B	0.00
GENPREX (GNPX)	United States	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.009B	0.00
Abpro Holdings (ABP)	United States	$0.008B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.008B	0.00
IMMURON (IMRN)	Australia	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.008B	0.00
GT Biopharma (GTBP)	United States	$0.008B	0.00
Mustang Bio (MBIO)	United States	$0.008B	0.00
Advanced Biomed (ADVB)	United States	$0.007B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.007B	0.00
MetaVia (MTVA)	United States	$0.007B	0.00
Synlogic (SYBX)	United States	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.006B	0.00
Aprea Therapeutics (APRE)	United States	$0.006B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.006B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
KALA BIO (KALA)	United States	$0.006B	0.00
BioAffinity Technologies (BIAF)	United States	$0.006B	0.00
Revelation Biosciences (REVB)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.005B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Silo Pharma (SILO)	United States	$0.005B	0.00
Avalon GloboCare (ALBT)	United States	$0.005B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.005B	0.00
HCW Biologics (HCWB)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.004B	0.00
Ensysce Biosciences (ENSC)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
GeoVax Labs (GOVX)	United States	$0.003B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
Onconetix (ONCO)	United States	$0.003B	0.00
Enveric Biosciences (ENVB)	United States	$0.002B	0.00
Dermata Therapeutics (DRMA)	United States	$0.002B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
GRI Bio (GRI)	United States	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
Psyence Biomedical (PBM)	Canada	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00